Human t-cell lymphotropic virus type I (HTLV-I) - Related clinical and laboratory findings for HTLV-I-infected blood donors

被引:11
|
作者
Furukawa, Y
Kubota, R
Eiraku, N
Nakagawa, IM
Usuku, T
Izumo, S
Osame, M
机构
[1] Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Fac Med, Dept Med Informat, Kagoshima 8908520, Japan
[3] Kagoshima Univ, Fac Med, Ctr Chron Viral Dis, Kagoshima 8908520, Japan
关键词
HTLV-I; blood donors; preclinical symptoms; sexual transmission; HTLV-I subgroup;
D O I
10.1097/00126334-200303010-00013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Clinical and laboratory findings were examined for 111 human T-cell lymphotropic virus type I (HTLV-I)-infected blood donors. HTLV-1 provirus loads in subjects with a family history of adult T-cell leukemia (ATL) or HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) tended to be higher than those in subjects without a family history of these conditions. There were 3 asymptomatic patients with ATL, 4 with a history of uveitis, 7 with hyperreflexia in the lower limbs, and 3 with urinary frequency in the night. The mean CD4 cell/CD8 cell ratio +/- SD was significantly lower (p < .0001) in subjects with hyperreflexia in the lower limbs (1.3 +/- 0.2) than in subjects without any clinical abnormalities (1.7 +/- 0.6), suggesting that subjects with hyperreflexia in the lower limbs already have some immunologic abnormalities. The concordance of HTLV-1 infection between husband and wife was lower in this study than in a previous study. HTLV-I-related inflammatory symptoms were more frequent (p = .021, Fisher exact test; OR = 9.5; 95% CI, 1.7-53.5) in HTLV-I tax A-infected donors (3 [50%] of 6 donors) than in HTLV-I tax B-infected donors (10 [9.5%] of 105 donors), suggesting different risks of HTLV-I-related symptoms according to the virus genotype.
引用
收藏
页码:328 / 334
页数:7
相关论文
共 50 条
  • [1] DIFFERENT B-CELL RESPONSES TO HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) ENVELOPE SYNTHETIC PEPTIDES IN HTLV-I-INFECTED INDIVIDUALS
    IDA, H
    KURATA, A
    EGUCHI, K
    KAWAKAMI, A
    MIGITA, K
    FUKUDA, T
    NAKAMURA, T
    KUSUMOTO, Y
    BERZOFSKY, JA
    NAGATAKI, S
    [J]. JOURNAL OF CLINICAL IMMUNOLOGY, 1991, 11 (03) : 143 - 151
  • [2] Complement-dependent cytotoxic antibodies to human T lymphotropic virus type I (HTLV-I)-infected cells in the sera of HTLV-I-infected individuals
    PlotnickyGilquin, H
    Afani, A
    Vernant, JC
    Desgranges, C
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (01): : 39 - 45
  • [3] Human T-lymphotropic virus type I (HTLV-I)
    Merle, H
    Smadja, D
    Vernant, JC
    [J]. JOURNAL OF NEURO-OPHTHALMOLOGY, 1996, 16 (01) : 68 - 69
  • [4] Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I)
    Edlich, RF
    Arnette, JA
    Williams, FM
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2000, 18 (01): : 109 - 119
  • [5] Dermatological manifestations of individuals infected with human T cell lymphotropic virus type I (HTLV-I)
    Dantas, Lorena
    Netto, Eduardo
    Glesby, Marshall J.
    Carvalho, Edgar M.
    Machado, Paulo
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2014, 53 (09) : 1098 - 1102
  • [6] Antibodies to human T-cell lymphotropic virus type I (HTLV-I) by particle agglutination (PA) test in Korean blood donors
    Kim, JM
    Song, YG
    Oho, YC
    Park, HC
    Kwon, KH
    Kim, E
    Lee, SH
    Kim, KH
    [J]. YONSEI MEDICAL JOURNAL, 1999, 40 (02) : 173 - 177
  • [7] THE HUMAN LYMPHOTROPIC VIRUS TYPE-I (HTLV-I)
    VALLEJO, A
    SORIANO, V
    [J]. MEDICINA CLINICA, 1995, 104 (11): : 426 - 435
  • [8] A SURVEY OF THE HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-I (HTLV-I) IN SOUTHWESTERN COLOMBIA
    MALONEY, EM
    RAMIREZ, H
    LEVIN, A
    BLATTNER, WA
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (03) : 419 - 423
  • [9] Phylogenetic analysis of human T-cell lymphotropic viruses type I (HTLV-I)
    Kashima, S
    Alcântara, LCJ
    Takayanagui, OM
    Carreto, R
    Galvao-Castro, B
    Covas, DT
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 : S38 - S38
  • [10] Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors.
    Schreiber, G
    Murphy, E
    Horton, J
    Nass, C
    [J]. TRANSFUSION, 1996, 36 (09) : S172 - S172